Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy.
Recent advances in the molecular biology, diagnosis and novel therapies for various small blue cell tumors.
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy.
Dynamic Phenotypic Switching and Group Behavior Help Non-Small Cell Lung Cancer Cells Evade Chemotherapy. Biomolecules. 2021 12 21; 12(1).
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Cisplatin
Drug Resistance, Neoplasm
Humans
Lung Neoplasms
Models, Biological
authors with profiles
Ravi Salgia